Amanote Research
Register
Sign In
Discovery of S-(2-Guanidylethyl)-Isothiourea (VUF 8430) as a Potent Nonimidazole Histamine H4 Receptor Agonist
doi 10.1021/jm060880d.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
A Potent Peptide as Adiponectin Receptor 1 Agonist to Against Fibrosis
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications
Frontiers in Pharmacology
Pharmacology
The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Discovery of Vibegron: A Potent and Selective 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder
TRPV1 and PLC Participate in Histamine H4 Receptor-Induced Itch
Neural Plasticity
Neurology
Converting Parathyroid Hormone-Related Peptide (PTHrP) Into a Potent PTH-2 Receptor Agonist
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Histamine H4 Receptor Insights Into a Potential Therapeutic Target in Breast Cancer
Frontiers in Bioscience - Scholar
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Histamine H1-Receptor-Mediated Inositol Phospholipid Hydrolysis in DDT1MF-2 Cells: Agonist and Antagonist Properties
British Journal of Pharmacology
Pharmacology
Front Cover: The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders (ChemMedChem 13/2019)
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
